Evidence map›Paper›PMID 34000300›Full record

ArticleThe Journal of biological chemistry

Heterologous functional expression of ascidian Nav1 channels and close relationship with the evolutionary ancestor of vertebrate Nav channels.

Takafumi Kawai, Masaki Hashimoto, Natsuki Eguchi, Junko M Nishino, Yuka Jinno, Risa Mori-Kreiner, Måns Aspåker, Daijiro Chiba, Yukio Ohtsuka, Akira Kawanabe and 2 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Takafumi KawaiIntegrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Japan.
Masaki HashimotoGraduate School of Frontier Bioscience, Osaka University, Suita, Japan.
Natsuki EguchiUC Davis, Davis, California, USA.
Junko M NishinoDepartment of Biology, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki, Japan; Department of Bioresources Science, United Graduate School of Agricultural Sciences, Iwate University, Hirosaki, Japan.
Yuka JinnoIntegrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Japan.
Risa Mori-KreinerIntegrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Japan.
Måns AspåkerUppsala University, Uppsala, Sweden.
Daijiro ChibaDepartment of Biology, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki, Japan.
Yukio OhtsukaBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki, Japan.
Akira KawanabeIntegrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Japan.
Atsuo S NishinoDepartment of Biology, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki, Japan; Department of Bioresources Science, United Graduate School of Agricultural Sciences, Iwate University, Hirosaki, Japan.
Yasushi OkamuraIntegrative Physiology, Department of Physiology, Graduate School of Medicine, Osaka University, Suita, Japan; Graduate School of Frontier Bioscience, Osaka University, Suita, Japan. Electronic address: vsop1@me.com.
The University of Osaka · JPHirosaki University · JPNational Institute of Advanced Industrial Science and Technology · JPUniversity of California, Davis · USUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Voltage-gated sodium channels (Nav1s) are responsible for the initiation and propagation of action potentials in neurons, muscle, and endocrine cells. Many clinically used drugs such as local anesthetics and antiarrhythmics inhibit Nav1s, and a variety of inherited human disorders are caused by mutations in Nav1 genes. Nav1s consist of the main α subunit and several auxiliary β subunits. Detailed information on the structure-function relationships of Nav1 subunits has been obtained through heterologous expression experiments and analyses of protein structures. The basic properties of Nav1s, including their gating and ion permeation, were classically described in the squid giant axon and other invertebrates. However, heterologous functional expression of Nav1s from marine invertebrates has been unsuccessful. Ascidians belong to the Urochordata, a sister group of vertebrates, and the larval central nervous system of ascidians shows a similar plan to that of vertebrates. Here, we report the biophysical properties of ascidian Ciona Nav1 (CiNav1a) heterologously expressed in Xenopus oocytes. CiNav1a exhibited tetrodotoxin-insensitive sodium currents with rapid gating kinetics of activation and inactivation. Furthermore, consistent with the fact that the Ciona genome lacks orthologous genes to vertebrate β subunits, the human β1 subunit did not influence the gating properties when coexpressed with CiNav1a. Interestingly, CiNav1a contains an ankyrin-binding motif in the II-III linker, which can be targeted to the axon initial segment of mammalian cortical neurons. Our findings provide a platform to gain insight into the evolutionary and biophysical properties of Nav1s, which are important for the development of targeted therapeutics.

Indexed as

AnimalsCiona intestinalisGene ExpressionPhylogenySodiumVoltage-Gated Sodium ChannelsXenopusSodiumVoltage-Gated Sodium Channelsankyrinascidianaxon initial segmentchordatecut-open oocyteevolutioninactivationion channelsodium channelvoltage clamp

Identifiers

PMID34000300
PMCPMC8192821
OpenAlexW3160755434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.